Forte Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -19 | 45 | -17 | -15 |
EBITDA | -21,744 | -23,732 | -17,665 | -11,234 |
EBIT | -21,763 | -23,751 | -17,682 | -11,249 |
Net Income | -22,136 | -24,788 | -17,682 | -11,249 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,808 | -16,466 | -14,055 | -10,061 |
Cash | 58,223 | 76,957 | 93,414 | 106,144 |
Basic Shares | 178,374 | 147,177 | 17,793 | 11,744 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -64 | -39 | -9 | |
EBITDA | -68,274 | -35,439 | -31,467 | -13,896 |
EBIT | -68,338 | -35,478 | -31,476 | -13,896 |
Net Income | -69,375 | -35,478 | -31,476 | -13,862 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -50,998 | -30,782 | -28,794 | -8,185 |
Cash | 76,957 | 22,244 | 11,961 | 41,100 |
Basic Shares | 147,177 | 2,915 | 1,262 | 695 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.24 |
2025-12-31 | -$1.45 |
2025-09-30 | -$0.99 |
2025-06-30 | -$0.96 |